Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stavros Apostolakis

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Thrombosis Research|February 17, 2006
Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery diseaseStavros Apostolakis, Stavroula Baritaki, Georgios E Kochiadakis, et al.
Pharmacoeconomics|October 3, 2013
Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulantsCharalampos Kasmeridis, Stavros Apostolakis, Lars Ehlers, et al.
The Pediatric Infectious Disease Journal|December 29, 2007
RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitisVirginia Amanatidou, George Sourvinos, Stavros Apostolakis, et al.
Thrombosis Research|February 10, 2009
Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Vassilis Voudris, Stavros Apostolakis, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2010
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery diseaseAndy Tsapaki, Apostolos Zaravinos, Stavros Apostolakis, et al.
The British Journal of Cardiology|June 24, 2022
ECG changes in hospitalised patients with COVID-19 infectionMengshi Yuan, Zafraan Zathar, Frantisek Nihaj, et al.
Thrombosis Research|August 2, 2011
Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysmsKonstantinos Tsarouhas, Christina Tsitsimpikou, Stavros Apostolakis, et al.
Thrombosis and Haemostasis|April 28, 2012
Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathwaysEduard Shantsila, Silvia Montoro-García, Luke D Tapp, et al.
Atherosclerosis|March 4, 2014
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysisEduard Shantsila, Luke D Tapp, Benjamin J Wrigley, et al.
American Heart Journal|January 21, 2014
Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillationKonstantinos V Voudris, Stavros Apostolakis, Panagiotis Karyofillis, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Thrombosis Research|February 17, 2006
Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery diseaseStavros Apostolakis, Stavroula Baritaki, Georgios E Kochiadakis, et al.
Pharmacoeconomics|October 3, 2013
Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulantsCharalampos Kasmeridis, Stavros Apostolakis, Lars Ehlers, et al.
The Pediatric Infectious Disease Journal|December 29, 2007
RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitisVirginia Amanatidou, George Sourvinos, Stavros Apostolakis, et al.
Thrombosis Research|February 10, 2009
Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Vassilis Voudris, Stavros Apostolakis, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2010
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery diseaseAndy Tsapaki, Apostolos Zaravinos, Stavros Apostolakis, et al.
The British Journal of Cardiology|June 24, 2022
ECG changes in hospitalised patients with COVID-19 infectionMengshi Yuan, Zafraan Zathar, Frantisek Nihaj, et al.
Thrombosis Research|August 2, 2011
Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysmsKonstantinos Tsarouhas, Christina Tsitsimpikou, Stavros Apostolakis, et al.
Thrombosis and Haemostasis|April 28, 2012
Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathwaysEduard Shantsila, Silvia Montoro-García, Luke D Tapp, et al.
Atherosclerosis|March 4, 2014
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysisEduard Shantsila, Luke D Tapp, Benjamin J Wrigley, et al.
American Heart Journal|January 21, 2014
Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillationKonstantinos V Voudris, Stavros Apostolakis, Panagiotis Karyofillis, et al.
Pageof 9